Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck

Strahlentherapie und Onkologie

Volumn 189, Issue 10, 2013, Pages 856-860

  Rades, D ^a   Seibold, N D ^a   Gebhard, M P ^a   Noack, F ^a   Thorns, C ^a   Schild, S E ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Head and neck cancer; HPV status; prognostic factors; Radiotherapy; Treatment outcomes

Indexed keywords

HEMOGLOBIN; PROTEIN P16;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; RECURRENCE RISK; TREATMENT OUTCOME; TUMOR CELL; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 84887275252     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0377-3     Document Type: Article

References (15)

1. Cerezo L, Millan I, Torre A et al (1992) Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69:1224-1234
2. Cvek J, Kubes J, Skacelikova E et al (2012) Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study. Strahlenther Onkol 188:666-670
3. Denis F, Garaud P, Bardet E et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69-76
4. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261-269
5. Hong AM, Dobbins TA, Lee CS et al (2010) Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103:1510-1517
6. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
7. Lee WR, Berkey B, Marcial V et al (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42:1069-1075
8. Leemans CR, Tiwari R, Nauta JJ et al (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71:452-456
9. Leibel SA, Scott CB, Mohiuddin M et al (1991) The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 21:549-556
10. Marur S, D'Souza, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781-789
11. Nguyen NP, Vock J, Chi A et al (2012) Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer. Strahlenther Onkol 188:677-685
12. Petersen I, Schewe C, Schlüns K et al (2007) Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch 451:701-716
13. Rades D, Seibold ND, Gebhard MP et al (2011) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626-632
14. Rades D, Stoehr M, Kazic N et al (2008) Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys 70:1108-1114
15. Wentzensen N, Knebel-Doeberitz M (2004) Viral cancerogenesis of head and neck tumors. Pathologe 25:21-30